Abstract
As malaria continues to be a worldwide problem due to increasing drug resistance, several drug susceptibility techniques have been reported in the literature. A particularly confounding problem is the lack of standardization between methods that result in differences in sensitivities. In this review, we report on the types of antimalarial drug susceptibility assays available to clinical and research investigators. Techniques based on enzyme-linked immunosorbent assays (ELISAs), fluorescence, molecular assays, and optical methods will be outlined. Strengths and weaknesses, as well as field applicability, will be discussed. Furthermore, assay and culture conditions, particularly for the fluorescence-based assays, will also be detailed.
Keywords: Antimalarials, drug susceptibility, ELISA, fluorescence, molecular assays, real-time polymerase chain reaction, optical imaging, Plasmodium
Anti-Infective Agents in Medicinal Chemistry
Title: Recent Methods in Antimalarial Susceptibility Testing
Volume: 9 Issue: 3
Author(s): E.M.A. Co, S.M. Johnson, T. Murthy, M. Talwar, M.R. Hickman and J.D. Johnson
Affiliation:
Keywords: Antimalarials, drug susceptibility, ELISA, fluorescence, molecular assays, real-time polymerase chain reaction, optical imaging, Plasmodium
Abstract: As malaria continues to be a worldwide problem due to increasing drug resistance, several drug susceptibility techniques have been reported in the literature. A particularly confounding problem is the lack of standardization between methods that result in differences in sensitivities. In this review, we report on the types of antimalarial drug susceptibility assays available to clinical and research investigators. Techniques based on enzyme-linked immunosorbent assays (ELISAs), fluorescence, molecular assays, and optical methods will be outlined. Strengths and weaknesses, as well as field applicability, will be discussed. Furthermore, assay and culture conditions, particularly for the fluorescence-based assays, will also be detailed.
Export Options
About this article
Cite this article as:
Co E.M.A., Johnson S.M., Murthy T., Talwar M., Hickman M.R. and Johnson J.D., Recent Methods in Antimalarial Susceptibility Testing, Anti-Infective Agents in Medicinal Chemistry 2010; 9 (3) . https://dx.doi.org/10.2174/1871521411009030148
DOI https://dx.doi.org/10.2174/1871521411009030148 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
Mini-Review: Nucleus-Targeted Ribonucleases As Antitumor Drugs
Current Medicinal Chemistry Application of Radioisotopes in Anti-Fungal Research and Fungal Disease Studies
Current Medicinal Chemistry - Anti-Infective Agents Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression
Current Medicinal Chemistry Autoimmunity and Celiac Disease
Mini-Reviews in Medicinal Chemistry Biphasic Lipid Vesicles (Biphasix™) Enhance the Adjuvanticity of CpG Oligonucleotides Following Systemic and Mucosal Administration
Current Drug Delivery Biology and Clinical Relevance of Mannose-Binding Lectin
Drug Design Reviews - Online (Discontinued) Targeting MAPK Signalling: Prometheus Fire or Pandoras Box?
Current Pharmaceutical Design Estrogens and Glucocorticoid Hormones in Adipose Tissue Metabolism
Current Medicinal Chemistry Early Development of Therapeutic Biologics - Pharmacokinetics
Current Drug Metabolism Epitope Mapping and Identification of Amino Acids Critical for Rabbits IgG-Binding to Linear Epitopes on Buffalo beta-lactoglobulin
Protein & Peptide Letters Increasing Progenitor Cell Proliferation in the Sub-Ventricular Zone: A Therapeutic Treatment for Progressive Multiple Sclerosis?
Recent Patents on Drug Delivery & Formulation Preventative and Therapeutic Potential of Lipopolysaccharide Derived from Edible Gram-Negative Bacteria to Various Diseases
Current Drug Therapy Subject Index To Volume 12
Current Pharmaceutical Design “Something is Wrong in the Ras Kingdom” - Evidence for the Involvement of p21Ras/MAP Kinase in Autoimmune Diseases
Current Rheumatology Reviews Preface [HotTopic: Cytokine Therapies for Diabetic Microvascular Complications (Executive Editor: J.L. Wilkinson-Berka)]
Current Pharmaceutical Design Single-Dose Microparticle Delivery of a Malaria Transmission- Blocking Vaccine Elicits a Long-Lasting Functional Antibody Response
Current Molecular Medicine Inflammation Fueling Atrial Fibrillation Substrate: Seeking Ways to "Cool" the Heart
Medicinal Chemistry MicroRNAs in Colorectal Neoplasia: From Pathobiology to Clinical Applications
Current Pharmaceutical Biotechnology Potential Novel Treatments for Bipolar Depression: Ketamine, Fatty Acids, Anti-inflammatory Agents, and Probiotics
CNS & Neurological Disorders - Drug Targets Sphingolipids in Inflammation: Roles and Implications
Current Molecular Medicine